Home
Blue Owl Capital Holdings reported a 5.54% stake in Context Therapeutics CNTX · 5,089,015 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 5.54%
- Last report
- 8.48% · filed 25/02/14
- Shares held
- 5,089,015 sh
- Class
- Common Stock, par value $0.001 per share
- Event date
- 26/03/31
- Filed
- 26/05/14
5.54% stake · −2.9pp from the last report
- Stake
- 5.54%
- Last report
- 8.48%
- Since last report
- −2.9pp
Context Therapeutics trades, last 26 weeks
What else happened in Context Therapeutics around then
Filed or reported within 30 days of the trade day · 03/01~04/30Blue Owl Capital Holdings's other 5% stake reports
- Blue Owl Capital Holdings
5% stakeContext Therapeutics
5% stakeContext Therapeutics
CNTX
3.19% stake
2,934,015 sh
3.19% stake
Filed 08/12
- Blue Owl Capital Holdings
5% stakeAktis Oncology
5% stakeAktis Oncology
AKTS
5.92% stake
3,161,348 sh
5.92% stake
Filed 05/14
- Blue Owl Capital Holdings
5% stakeImageneBio
5% stakeImageneBio
IMA
8.51% stake
959,337 sh
8.51% stake
Filed 05/14
- Blue Owl Capital Holdings
5% stakeFinance of America Companies
5% stakeFinance of America Companies
FOA
9.49% stake
827,409 sh
9.49% stake
Filed 02/12
- Blue Owl Capital Holdings
5% stakeFS Credit Opportunities
5% stakeFS Credit Opportunities
FSCO
0% stake
0 sh
0% stake
Filed 02/12
